Product quality enhancement in mammalian cell culture processes for protein production

Details for Australian Patent Application No. 2003303394 (hide)

Owner Bristol-Myers Squibb Company

Inventors Schilling, Bernhard M.; Joosten, Christoph E.; Basch, Jonathan D.; Lee, Steven S.; Matlock, Linda; Kothari, Dharti; Gangloff, Scott; Zegarelli, Stephen G.; Sakhamuri, Sivakesava; Leister, Kirk

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003303394

PCT Number PCT/US2003/0409

PCT Pub. Number WO2004/058944

Priority 60/436,050 23.12.02 US

Filing date 18 December 2003

Wipo publication date 22 July 2004

Acceptance publication date 19 February 2009

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

19 August 2004 Complete Application Filed

  Priority application(s): 60/436,050 23.12.02 US

26 August 2004 Application Open to Public Inspection

  Published as AU-B-2003303394

1 September 2005 Amendment Made

  The nature of the amendment is: Amend the name of the inventors to read Schilling, Bernhard M., Gangloff, Scott, Kothari, Dharti, Lee, Steven S., Leister, Kirk, Matlock, Linda, Zegarelli, Stephen G., Joosten, Christoph E., Basch, Jonathan D., Sakhamuri, Sivakesava 2004

19 February 2009 Application Accepted

  Published as AU-B-2003303394

18 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003303395-TARGET-DEPENDENT TRANSCRIPTION USING DELETION MUTANTS OF N4 RNA POLYMERASE

2003303393-AUTOMATED SALES CENTER